J 2021

Association of Acute Kidney Injury with the Risk of Dementia: A Meta-Analysis

HUSSAIN, Mohammad Salman, A. SINGH, B. ANTONY, Granado R. CLAURE-DEL, Jitka KLUGAROVÁ et. al.

Základní údaje

Originální název

Association of Acute Kidney Injury with the Risk of Dementia: A Meta-Analysis

Autoři

HUSSAIN, Mohammad Salman (356 Indie, domácí), A. SINGH, B. ANTONY, Granado R. CLAURE-DEL, Jitka KLUGAROVÁ (203 Česká republika, domácí), Radim LÍČENÍK (203 Česká republika, domácí) a Miloslav KLUGAR (203 Česká republika, domácí)

Vydání

Journal of Clinical Medicine, Basel, MDPI, 2021, 2077-0383

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30217 Urology and nephrology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.964

Kód RIV

RIV/00216224:14110/21:00123256

Organizační jednotka

Lékařská fakulta

UT WoS

000777191400013

Klíčová slova anglicky

acute kidney injury; dementia; dialysis; epidemiology; systematic review; meta-analysis

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 26. 4. 2022 10:45, Mgr. Tereza Miškechová

Anotace

V originále

cute kidney injury (AKI) is associated with several adverse outcomes, including new or progressive chronic kidney disease, end-stage kidney disease, and mortality. Epidemiological studies have reported an association between AKI and dementia as a long-term adverse outcome. This meta-analysis was aimed to understand the association between AKI and dementia risk. A literature search was performed in MEDLINE and Embase databases, from inception to July 2021, to identify epidemiological studies reporting the association between AKI and dementia risk. Title and abstract followed by the full-text of retrieved articles were screened, data were extracted, and quality was assessed, using the Newcastle–Ottawa scale by two investigators independently. The primary outcome was to compute the pooled risk of dementia in AKI patients. Subgroup analysis was also performed based on age and co-morbidities. Certainty of evidence was assessed using the GRADE approach. Statistical analysis was performed using Review Manager 5.4 software. Four studies (cohort (n = 3) and case–control (n = 1)) with a total of 429,211 patients, of which 211,749 had AKI, were identified. The mean age of the patients and the follow-up period were 64.15 ± 16.09 years and 8.9 years, respectively. Included studies were of moderate to high quality. The pooled estimate revealed a significantly higher risk of dementia in AKI patients with an overall relative risk/risk ratio (RR) of 1.92 (95% CI: 1.52–2.43), p ≤ 0.00001. Dementia risk increases by 10% with one year increase in age with an RR of 1.10 (95% CI: 1.09–1.11), p < 0.00001. Subgroup analysis based on stroke as a co-morbid condition also revealed significantly higher dementia risk in AKI patients (RR 2.30 (95% CI: 1.62–3.28), p = 0.009). All-cause mortality risk was also significantly higher in AKI patients with dementia with a pooled RR of 2.11 (95% CI: 1.20–3.70), p = 0.009. The strength of the evidence was of very low certainty as per the GRADE assessment. Patients with AKI have a higher risk of dementia. Further large epidemiological studies are needed to confirm the mechanistic association.

Návaznosti

EF18_053/0016952, projekt VaV
Název: Postdoc2MUNI
LTC20031, projekt VaV
Název: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic, INTER-COST